DEXCOM, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
DEXCOM, INC. (DXCM) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $39.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $39.00M, a 13.91% decline year-over-year.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $43.30M, a 26.61% increase year-over-year.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $35.00M, a 19.17% decline year-over-year.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $45.10M, a 3.92% increase year-over-year.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $159.60M, a 6.34% decline from fiscal 2024.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $170.40M, a 13.00% increase from fiscal 2023.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $150.80M, a 19.21% increase from fiscal 2022.
- DEXCOM, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $126.50M, a 11.55% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.00M 10-Q · filed 2026-07-30 | $82.30M 10-Q · filed 2026-07-30 | $117.30M derived: sum of 3 quarters · filed 2026-07-30 | $162.40M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $43.30M 10-Q · filed 2026-04-30 | $78.30M derived: sum of 2 quarters · filed 2026-04-30 | $123.40M derived: sum of 3 quarters · filed 2026-04-30 | $168.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $80.10M derived: sum of 2 quarters · filed 2026-02-12 | $125.40M derived: sum of 3 quarters · filed 2026-07-30 | $159.60M 10-K · filed 2026-02-12 |
| 2025-09-30 | $45.10M 10-Q · filed 2025-10-30 | $90.40M derived: sum of 2 quarters · filed 2026-07-30 | $124.60M 10-Q · filed 2025-10-30 | $167.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $45.30M 10-Q · filed 2026-07-30 | $79.50M 10-Q · filed 2026-07-30 | $122.80M derived: sum of 3 quarters · filed 2026-07-30 | $166.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $34.20M 10-Q · filed 2026-04-30 | $77.50M derived: sum of 2 quarters · filed 2026-04-30 | $120.90M derived: sum of 3 quarters · filed 2026-04-30 | $165.60M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $43.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $86.70M derived: sum of 2 quarters · filed 2026-02-12 | $131.40M derived: sum of 3 quarters · filed 2026-02-12 | $170.40M 10-K · filed 2026-02-12 |
| 2024-09-30 | $43.40M 10-Q · filed 2025-10-30 | $88.10M derived: sum of 2 quarters · filed 2025-10-30 | $127.10M 10-Q · filed 2025-10-30 | $164.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $44.70M 10-Q · filed 2025-07-30 | $83.70M 10-Q · filed 2025-07-30 | $120.60M derived: sum of 3 quarters · filed 2026-02-12 | $159.60M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $39.00M 10-Q · filed 2025-05-01 | $75.90M derived: sum of 2 quarters · filed 2026-02-12 | $114.90M derived: sum of 3 quarters · filed 2026-02-12 | $154.60M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $36.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $75.90M derived: sum of 2 quarters · filed 2026-02-12 | $115.60M derived: sum of 3 quarters · filed 2026-02-12 | $150.80M 10-K · filed 2026-02-12 |
| 2023-09-30 | $39.00M 10-Q · filed 2024-10-24 | $78.70M derived: sum of 2 quarters · filed 2024-10-24 | $113.90M 10-Q · filed 2024-10-24 | $147.90M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $39.70M 10-Q · filed 2024-07-25 | $74.90M 10-Q · filed 2024-07-25 | $108.90M derived: sum of 3 quarters · filed 2025-02-18 | $139.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $35.20M 10-Q · filed 2024-04-25 | $69.20M derived: sum of 2 quarters · filed 2025-02-18 | $100.00M derived: sum of 3 quarters · filed 2025-02-18 | $132.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $64.80M derived: sum of 2 quarters · filed 2025-02-18 | $97.40M derived: sum of 3 quarters · filed 2025-02-18 | $126.50M 10-K · filed 2025-02-18 |
| 2022-09-30 | $30.80M 10-Q · filed 2023-10-26 | $63.40M derived: sum of 2 quarters · filed 2023-10-26 | $92.50M 10-Q · filed 2023-10-26 | $118.80M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $32.60M 10-Q · filed 2023-07-27 | $61.70M 10-Q · filed 2023-07-27 | $88.00M derived: sum of 3 quarters · filed 2024-02-08 | $115.50M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $29.10M 10-Q · filed 2023-04-27 | $55.40M derived: sum of 2 quarters · filed 2024-02-08 | $82.90M derived: sum of 3 quarters · filed 2024-02-08 | $114.50M derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | $26.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $53.80M derived: sum of 2 quarters · filed 2024-02-08 | $85.40M derived: sum of 3 quarters · filed 2024-02-08 | $113.40M 10-K · filed 2024-02-08 |
| 2021-09-30 | $27.50M 10-Q · filed 2022-10-27 | $59.10M derived: sum of 2 quarters · filed 2022-10-27 | $87.10M 10-Q · filed 2022-10-27 | $121.20M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $31.60M 10-Q · filed 2022-07-28 | $59.60M 10-Q · filed 2022-07-28 | $93.70M derived: sum of 3 quarters · filed 2023-02-09 | $124.40M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $28.00M 10-Q · filed 2022-04-28 | $62.10M derived: sum of 2 quarters · filed 2023-02-09 | $92.80M derived: sum of 3 quarters · filed 2023-02-09 | $123.50M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $34.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $64.80M derived: sum of 2 quarters · filed 2023-02-09 | $95.50M derived: sum of 3 quarters · filed 2023-02-09 | $119.40M 10-K · filed 2023-02-09 |
| 2020-09-30 | $30.70M 10-Q · filed 2021-10-28 | $61.40M derived: sum of 2 quarters · filed 2021-10-28 | $85.30M 10-Q · filed 2021-10-28 | $108.90M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $30.70M 10-Q · filed 2021-07-29 | $54.60M 10-Q · filed 2021-07-29 | $78.20M derived: sum of 3 quarters · filed 2022-02-14 | $102.60M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $23.90M 10-Q · filed 2021-04-29 | $47.50M derived: sum of 2 quarters · filed 2022-02-14 | $71.90M derived: sum of 3 quarters · filed 2022-02-14 | $101.60M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $23.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $48.00M derived: sum of 2 quarters · filed 2022-02-14 | $77.70M derived: sum of 3 quarters · filed 2022-02-14 | $102.70M 10-K · filed 2022-02-14 |
| 2019-09-30 | $24.40M 10-Q · filed 2020-10-27 | $54.10M derived: sum of 2 quarters · filed 2020-10-27 | $79.10M 10-Q · filed 2020-10-27 | $103.70M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $29.70M 10-Q · filed 2020-07-28 | $54.70M 10-Q · filed 2020-07-28 | $79.30M derived: sum of 3 quarters · filed 2021-02-11 | $106.40M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $25.00M 10-Q · filed 2020-04-28 | $49.60M derived: sum of 2 quarters · filed 2021-02-11 | $76.70M derived: sum of 3 quarters · filed 2021-02-11 | $102.30M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $24.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $51.70M derived: sum of 2 quarters · filed 2021-02-11 | $77.30M derived: sum of 3 quarters · filed 2021-02-11 | $101.90M 10-K · filed 2021-02-11 |
| 2018-09-30 | $27.10M 10-Q · filed 2019-11-06 | $52.70M derived: sum of 2 quarters · filed 2019-11-06 | $77.30M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $25.60M 10-Q · filed 2019-07-31 | $50.20M 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $24.60M 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $106.70M 10-K · filed 2020-02-13 | |||
| 2016-12-31 | $111.30M 10-K · filed 2019-02-21 | |||
| 2015-12-31 | $83.20M 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $50.50M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $24.80M 10-K · filed 2016-02-23 | |||
| 2012-12-31 | $18.40M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | $13.50M 10-K · filed 2014-02-20 | |||
| 2010-12-31 | $9.50M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |